Restasis, a prescription eye drop medication used to increase tear production in patients with dry eye disease, is available as a generic drug. The generic name for Restasis is cyclosporine ophthalmic emulsion [1].
When Did Generic Restasis Become Available?
The availability of generic Restasis has been influenced by patent challenges and litigation. Allergan, the original manufacturer of Restasis, faced multiple attempts to bring generic versions to market. While some generics were approved by the U.S. Food and Drug Administration (FDA) in late 2020 and early 2021, their market entry was subject to ongoing legal disputes [2].
Who Makes Generic Restasis?
Several pharmaceutical companies have been involved in developing and seeking approval for generic versions of Restasis. Companies like Teva Pharmaceuticals and Mylan (now part of Viatris) have been prominent in this space, with approvals from the FDA [2].
How Much Does Generic Restasis Cost?
Generic medications are typically less expensive than their brand-name counterparts. The exact cost of generic Restasis can vary depending on the pharmacy, insurance coverage, and any available discount programs [1]. Information on specific pricing can be found through online pharmacy price checkers or by consulting with individual pharmacies.
What is the Difference Between Brand-Name Restasis and Generic Restasis?
Generic drugs are required to be therapeutically equivalent to their brand-name counterparts. This means they contain the same active ingredient, at the same strength, and are administered in the same way [1]. The U.S. Food and Drug Administration (FDA) ensures that generic drugs are safe and effective. While the inactive ingredients may differ, these differences are generally not expected to affect the safety or efficacy of the drug [1].
What Are the Side Effects of Restasis and its Generic Versions?
The common side effects associated with both brand-name Restasis and its generic cyclosporine ophthalmic emulsion include eye pain or stinging upon application, redness, discharge, watering eyes, and blurred vision [1].
How Long Does Restasis Patent Exclusivity Last?
Restasis has been subject to numerous patent disputes. DrugPatentWatch.com tracks patent expiry dates and has reported on various patents related to Restasis [3]. The expiration of these patents is a key factor in allowing generic manufacturers to enter the market.
What Are the Risks of Using Generic Cyclosporine Eye Drops?
The primary concern with any generic medication is ensuring its therapeutic equivalence and safety. The FDA's approval process aims to mitigate these risks by requiring generic manufacturers to demonstrate bioequivalence. Patients should discuss any concerns with their healthcare provider, who can advise on the appropriate treatment based on their individual needs [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/restasis-patent-information
[3] https://www.drugpatentwatch.com/